Cannabis Company News

Canopy Growth Statement on Cannabis Task Force Report

SMITHS FALLS, ON, Dec. 13, 2016 /CNW/ – After a preliminary review of the findings of the special Task Force which today released recommendations on the regulation of recreational...
- December 13th, 2016 at 3:11 pm

OrganiGram Reports FY16 Sales of $6.1mm

OrganiGram Reports Financial Results and Summary Update MONCTON, NEW BRUNSWICK–(Marketwired – Dec. 13, 2016) – OrganiGram Holdings Inc. (TSXV: OGI) (OTC: OGRMF) (the “Company”) announced the financial results for...
- December 13th, 2016 at 9:26 am

Florida CBD Producer Surterra Raises $15mm

Atlanta-based Surterra Holdings filed a Form D with the SEC on December 9th indicating it had raised $10.3mm from the sale of equity to 3 investors, with the first sale...
- December 12th, 2016 at 9:54 pm

Défoncé Chocolatier is Elevating Edibles

In episode 54 of Investing in Cannabis, Brandon David interviews Eric Eslao, CEO of Défoncé Chocolatier, touring the company’s new 10K sq. ft. facility in Oakland and learning more about one...
- December 10th, 2016 at 9:28 am

Maryland Names Medical Cannabis Dispensary License Pre-Approvals

Maryland Medical Cannabis Commission Announces 102 Dispensary License Pre-Approvals Baltimore, MD (December 9, 2016) – The Maryland Medical Cannabis Commission (“MMCC”) today announced the names of 102 Dispensary entities who have...
- December 9th, 2016 at 5:24 pm

Emblem to Begin Trading on the TSX Venture

Emblem Corp. Goes Public under Symbol EMC.V TORONTO, ONTARIO–(Marketwired – Dec. 8, 2016) – After much anticipation from the North American investment community, Emblem Corp. (TSXV: EMC) is set...
- December 8th, 2016 at 3:02 pm

Aurora Cannabis CEO Projects Profitability at Hand

Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) CEO Terry Booth was interviewed Friday by Andrew Bell of BNN, who began with a question about the company’s financials.  Booth stated that...
- December 6th, 2016 at 7:39 pm

GW Pharma Ends FY16 with $483mm in Cash

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress – Three Positive Phase 3 Epidiolex clinical trials reported in 2016 – – NDA submission...
- December 5th, 2016 at 7:52 am

GW Pharma Progresses Towards Epidiolex FDA Submission

GW Announces New Epidiolex® (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome – Posters Presented at American Epilepsy Society Annual Meeting – – New data includes...
- December 5th, 2016 at 7:39 am

Canopy Growth Forms Cannabis Research Incubator

Canopy Growth (TSX: CGC) (OTC: TWMJF) unveiled a new initiative today, Canopy Health Innovations (CHI), a cannabis research incubator that it formed in August. CHI will conduct exploratory studies...
- December 2nd, 2016 at 12:09 pm

Emblem to Supply Lift-Branded Cannabis

Emblem Corp. Signs Licensing Deal With Canada’s Leading Cannabis Platform Lift Co. TORONTO, ON–(Marketwired – November 30, 2016) – Lift Cannabis Co Ltd (“Lift”) announced today that it has...
- November 30th, 2016 at 2:16 pm